Publications by authors named "Mutsuo Harada"

Pulmonary hypertension (PH) is a life-threatening disease characterized by a progressive narrowing of pulmonary arterioles. Although VEGF is highly expressed in lung of patients with PH and in animal PH models, the involvement of angiogenesis remains elusive. To clarify the pathophysiological function of angiogenesis in PH, we compared the angiogenic response in hypoxia (Hx) and SU5416 (a VEGFR2 inhibitor) plus Hx (SuHx) mouse PH models using 3D imaging.

View Article and Find Full Text PDF

Cardiovascular disease (CVD) is a global health burden in the world. Although low-carbohydrate diets (LCDs) have beneficial effects on CVD risk, their preventive effects remain elusive. We investigated whether LCDs ameliorate heart failure (HF) using a murine model of pressure overload.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers created a mouse model using the Cre-loxP system that specifically inactivates non-nuclear signaling of the estrogen receptor-α in endothelial cells.
  • In this modified mouse model, the protective effects of estrogen against mechanical vascular injury were significantly reduced.
  • The findings highlight the crucial importance of non-nuclear signaling of endothelial estrogen receptor-α in providing vascular protection from estrogen.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how the heart changes after a heart attack (myocardial infarction) by analyzing gene expression in mice.
  • Researchers discovered that genes related to mechanical stress are active in a specific area (the border zone) around the damaged tissue and are key to how the heart remodels post-MI.
  • They found that a gene called Csrp3 is particularly important, as manipulating its levels can help prevent harmful cardiac remodeling, suggesting it plays a protective role in heart recovery.
View Article and Find Full Text PDF

Tissue fibrosis and organ dysfunction are hallmarks of age-related diseases including heart failure, but it remains elusive whether there is a common pathway to induce both events. Through single-cell RNA-seq, spatial transcriptomics, and genetic perturbation, we elucidate that high-temperature requirement A serine peptidase 3 (Htra3) is a critical regulator of cardiac fibrosis and heart failure by maintaining the identity of quiescent cardiac fibroblasts through degrading transforming growth factor-β (TGF-β). Pressure overload downregulates expression of Htra3 in cardiac fibroblasts and activated TGF-β signaling, which induces not only cardiac fibrosis but also heart failure through DNA damage accumulation and secretory phenotype induction in failing cardiomyocytes.

View Article and Find Full Text PDF

Most seven transmembrane receptors (7TMRs) are G protein-coupled receptors; however, some 7TMRs evoke intracellular signals through β-arrestin as a biased receptor. As several β-arrestin-biased agonists have been reported to be cardioprotective, we examined the role of the chemokine receptor CXCR7 as a β-arrestin-biased receptor in the heart. Among 510 7TMR genes examined, Cxcr7 was the most abundantly expressed in the murine heart.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how percutaneous coronary intervention (PCI) can lead to left ventricular reverse remodelling (LVRR) in patients with coronary artery disease (CAD) and reduced left ventricular ejection fraction (LVEF).
  • Among 4394 patients who underwent PCI, 286 with LVEF under 50% were analyzed, and LVRR was defined as a specific reduction in heart volume and improvement in ejection fraction after 6 months.
  • Results indicated that intervention on the unprotected left main coronary artery (LMCA) was positively linked to LVRR, while factors like prior PCI, in-stent restenosis, and new stenosis were associated with lower chances of LVRR occurring.
View Article and Find Full Text PDF

Increased transforming growth factor-β (TGF-β) signaling contributes to the pathophysiology of aortic aneurysm in Marfan syndrome (MFS). Recent reports indicate that a small but significant number of inflammatory cells are infiltrated into the aortic media and adventitia in MFS. However, little is known about the contribution of myeloid cells to aortic aneurysmal formation.

View Article and Find Full Text PDF

Some clinical trials showed that omega-3 fatty acid (FA) reduced cardiovascular events, but it remains unknown whether omega-3 FA supplementation changes the composition of FAs and their metabolites in the heart and how the changes, if any, exert beneficial effects on cardiac structure and function. To clarify these issues, we supplied omega-3 FA to mice exposed to pressure overload, and examined cardiac structure and function by echocardiography and a proportion of FAs and their metabolites by gas chromatography and liquid chromatography-tandem mass spectrometry, respectively. Pressure overload induced cardiac hypertrophy and dysfunction, and reduced concentration of all FAs' components and increased free form arachidonic acid and its metabolites, precursors of pro-inflammatory mediators in the heart.

View Article and Find Full Text PDF
Article Synopsis
  • This study used genetically engineered mice to investigate how non-nuclear signaling from estrogen receptor-α protects the heart during pressure overload by activating a specific protein kinase G pathway.
  • The findings revealed that this estrogen signaling is crucial for the effectiveness of certain heart medications (like phosphodiesterase 5 inhibitors) but not others (like soluble guanylate cyclase stimulators).
  • The results point to the importance of developing targeted heart failure treatments for women, especially post-menopause, given the differences in therapeutic effects observed.
View Article and Find Full Text PDF

Introduction: Metabolomics has recently emerged as a tool for understanding comprehensive tumor-associated metabolic dysregulation. However, only limited application of this technology has been introduced into the clinical setting of breast cancer.

Objectives: The aim of this study was to determine the feasibility of metabolome analysis using routine CNB/VAB samples from breast cancer patients and to elucidate metabolic signatures using metabolic profiling.

View Article and Find Full Text PDF

The 83Annual Scientific Meeting of the Japanese Circulation Society was held in Yokohama, Japan, on March 29-31, 2019, just as the cherry blossoms came into full bloom. Because the environment around cardiovascular healthcare is rapidly changing, it becomes highly important to make a breakthrough at the dawn of a new era. The main theme of this meeting was "Renaissance of Cardiology for the Creation of Future Medicine".

View Article and Find Full Text PDF

Heart disease is a paramount cause of global death and disability. Although cardiomyocyte death plays a causal role and its suppression would be logical, no clinical counter-measures target the responsible intracellular pathways. Therapeutic progress has been hampered by lack of preclinical human validation.

View Article and Find Full Text PDF

Background: The heart responds to hemodynamic overload through cardiac hypertrophy and activation of the fetal gene program. However, these changes have not been thoroughly examined in individual cardiomyocytes, and the relation between cardiomyocyte size and fetal gene expression remains elusive. We established a method of high-throughput single-molecule RNA imaging analysis of in vivo cardiomyocytes and determined spatial and temporal changes during the development of heart failure.

View Article and Find Full Text PDF

Accumulating data suggest that new cardiomyocytes in adults are generated from existing cardiomyocytes throughout life. To enhance the endogenous cardiac regeneration, we performed chemical screenings to identify compounds that activate pro-proliferative YES-associated protein and transcriptional enhancer factor domain activities in cardiomyocytes. We synthesized a novel fluorine-containing TT-10 (CHFNOS) from the biologically hit compound.

View Article and Find Full Text PDF

Pressure overload induces a transition from cardiac hypertrophy to heart failure, but its underlying mechanisms remain elusive. Here we reconstruct a trajectory of cardiomyocyte remodeling and clarify distinct cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure, by integrating single-cardiomyocyte transcriptome with cell morphology, epigenomic state and heart function. During early hypertrophy, cardiomyocytes activate mitochondrial translation/metabolism genes, whose expression is correlated with cell size and linked to ERK1/2 and NRF1/2 transcriptional networks.

View Article and Find Full Text PDF

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

View Article and Find Full Text PDF

Variants in TGFBR1 have been reported to induce two completely distinct diseases, namely Loeys-Dietz syndrome (LDS) and multiple self-healing squamous epithelioma (MSSE). However, detailed mechanisms underlying this effect remain unknown. We report a Japanese familial case of LDS with a novel splice donor site variant in TGFBR1 gene (c.

View Article and Find Full Text PDF

Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) are genetically and phenotypically heterogeneous. Cardiac function is improved after treatment in some cardiomyopathy patients, but little is known about genetic predictors of long-term outcomes and myocardial recovery following medical treatment. To elucidate the genetic basis of cardiomyopathy in Japan and the genotypes involved in prognosis and left ventricular reverse remodeling (LVRR), we performed targeted sequencing on 120 DCM (70 sporadic and 50 familial) and 52 HCM (15 sporadic and 37 familial) patients and integrated their genotypes with clinical phenotypes.

View Article and Find Full Text PDF

Emerging evidence has suggested a potential impact of gut microbiota on the pathophysiology of heart failure (HF). However, it is still unknown whether HF is associated with dysbiosis in gut microbiota. We investigated the composition of gut microbiota in patients with HF to elucidate whether gut microbial dysbiosis is associated with HF.

View Article and Find Full Text PDF